Citations

Showing 10 of 108152 citations.

Abstract 18019: Successful Surgical Management of Severely Symptomatic Hypertrophic Cardiomyopathy Patients With Minimal Septal Hypertrophy
Ahmad, Raabia N, Maron, Barry J. , Rowin, Ethan J. , Haas, Tammy S., Maron, Martin S. , Dearani, Joseph A.

Mayo Clinic

Circulation | July 3, 2021 | Volume: 130 | Issue: suppl_2 | Pages: No page available

10.1161/circ.130.suppl_2.18019 Get It

Background: Marked septal hypertrophy is considered a requirement for effective myectomy in obstructive hypertrophic cardiomyopathy (HCM), with mitral valve replacement recommended as the alternative strategy in patients with minimal hypertrophy. However, it remains uncertain whether relief of obstruction can be effectively abolished without mitral valve replacement in patients with minimal septal wall thickening. Methods: Of 500 patients who underwent surgical myectomy from 2004 to January 2014, 21 (4.2%) were identified with a maximum LV wall thickness ≤ 15mm and constitute the study cohort. Results: All 21 patients (56 ± 10 years old; 62% male) were followed for advanced heart failure symptoms refractory to drug therapy with a maximal septal wall thickness of 13.6 ± 1.7 mm (range: 10-15 mm; ≤ 12 mm in 5 patients). Outflow obstruction ≥ 30 mmHg due to mitral valve-septal contact was present after exercise in 17 of 21 patients (range: 50-150 mmHg), and under resting conditions in 4 patients (range: 30-65 mmHg). In all patients, surgical relief of obstruction consisted of muscular resection of the basal septum with revision of abnormal and apically displaced papillary muscles, which were judged intraoperatively to be contributing to obstruction. In addition, in 10 patients (47%) myectomy alone was not sufficient to relieve obstruction due to the limited opportunity for septal reduction and adjunctive mitral valve repair was performed to shorten an elongated anterior leaflet. No patient required mitral valve replacement or incurred a ventricular septal defect. Post-operatively, 4 patients developed complete heart block requiring permanent pacemaker (1 patient with pre-operative right bundle branch block) and 1 had a cerebrovascular event. At most recent follow up 18 ± 19 months post-myectomy, septal thickness was reduced to 10 ± 2 mm, no patient had an outflow gradient at rest or with provocation, and all patients were alive with the majority asymptomatic (class I: n=13; 62% and class II n=8; 38%). Conclusion: In patients with minimal septal hypertrophy, outflow obstruction can be effectively abolished with surgical myectomy and adjunctive mitral valve repair with a small increased risk of heart block, but without the need for mitral valve replacement.
Abstract 17983: Ankle-Brachial Index Predicts Progression of Aortic Stiffeness
Ye, Zi , Thais, Coutinho, Kullo, Iftikhar J.

Mayo Clinic

Circulation | July 3, 2021 | Volume: 130 | Issue: suppl_2 | Pages: No page available

10.1161/circ.130.suppl_2.17983 Get It

Background: Arterial stiffness is associated with increased risk for adverse cardiovascular outcome. Ankle-brachial index (ABI) is a measure reflective of systemic atherosclerosis. Whether it can predict central aortic stiffness and its progression is unknown. As such, we investigated the impact of ABI on carotid-femoral pulse wave velocity (cfPWV) and aortic characteristic impedance (Z c ) in apparently healthy adults from the community. Methods: Participants were from the GENOA study without cardiovascular disease at baseline (December 2000 to September 2006) and completed follow-up (September 2009 to December 2012) assessment (n=358, 63%women, 69% hypertensive). ABI was measured by standard protocol at baseline. cfPWV was measured by applanation tonometry. Difference in log-cfPWV between two visits ([[Unable to Display Character: &#8710;]]log-cfPWV) was used to estimate progression of aortic stiffness. Z c was ascertained at 2 nd visit using carotid tonometry followed by echocardiography (Cardiovascular Engineering Inc., Norwood). Results: After a mean follow-up of 8.5±0.9 years, cfPWV increased from 9.3±2.4m/s to 11.1±5.0m/s. After adjusted for age, sex and time-interval between two visits, lower ABI was associated with greater [[Unable to Display Character: &#8710;]]log-cfPWV (β±SE:-0.41±0.15), and increased risk for higher log-cfPWV (β±SE:-0.38±0.12) and higher log-Z c at 2 nd visit (β±SE:-0.38±0.18) (all P≤0.04). Diabetes and renal function at baseline were predictors for higher cfPWV and Z c ; hypertension and metabolic syndrome were only predictors of cfPWV; while age and male gender were major predictors for [[Unable to Display Character: &#8710;]]log-cfPWV (all P≤0.04). The association of ABI with cfPWV or Z c remained significant after adjustment for these covariates (both P<0.05). Greater [[Unable to Display Character: &#8710;]]log-cfPWV was associated with increased risk for higher log-Z c ; longer time-interval amplified this effect (both p for [[Unable to Display Character: &#8710;]]log-cfPWV and [[Unable to Display Character: &#8710;]]log-cfPWV x time-interval ≤0.03). Conclusions: Lower ABI predicts progression of aortic stiffness, leading to both increased aortic wall stiffness (PWV) and greater aortic area-flow mismatch (Z c ), suggesting the impact of subclinical atherosclerosis on proximal aortic stiffening.
Abstract 17940: PDEV Inhibition + BNP Administration Enhanced the Cardiac but not the Renal Response to Acute Volume Overload in Human Preclinical Diastolic Dysfunction as Compared to PDEV Inhibition Alone
Torres-Courchoud, Isabel, Benike, Sherry L., Schirger, John A., Redfield, Margaret M. , Burnett, John C. , Chen, Horng H. , McKie, Paul M.

Mayo Clinic

Circulation | July 3, 2021 | Volume: 130 | Issue: suppl_2 | Pages: No page available

10.1161/circ.130.suppl_2.17940 Get It

Background: Preclinical diastolic dysfunction (PDD) is defined as subjects with normal systolic function, moderate or severe diastolic dysfunction determined by Doppler criteria but with no symptoms of heart failure (HF). We have previously demonstrated that an impaired cardiorenal endocrine response to stress by acute volume loading (AVL) exists in PDD and that is corrected by acute administration of sq B-type natriuretic peptide (BNP). Type V phosphodiesterase (PDEV) metabolizes cGMP, second messenger of BNP. The objective of the current study is to determine if the combination of PDEV inhibitor (PDEVI) and BNP will result in a greater enhancement of the cardiorenal response to AVL as compared to PDEVI alone in PDD. Methods: Randomized double-blind single placebo-controlled cross-over study in 20 PSD subjects. We determined cardiorenal effects of PDEVI with Tadalafil (T) 5 mg alone and in combination with acute sq BNP (Nesiritide 10 μg/Kg), in response to AVL (normal saline 0.25 ml/kg/min for 1 hour). Each subject had 2 study visits, separated by at least 1 week. At each visit, echocardiogram and renal clearance studies with iothalmate and PAH to measure GFR and renal plasma flow (RPF) were done before and after AVL. Each patient was randomized to receive T at both visits and either placebo or sq-BNP one visit and crossover to the other on the next visit. Results: T+BNP resulted in smaller LA volume index (-4±10 vs 3±7 ml/m 2 , p< 0.05) and lower right ventricular systolic pressure (-4±3 vs 2±6 mmHg, p< 0.05) in response to AVL as compared to T alone. Moreover, T+ BNP resulted in a significant reduction of plasma ANP and LV end-systolic volume in response to AVL while T alone did not. However, the combination to T+BNP did not enhance the renal response to AVL as compared to T alone. Both the change in urine flow (1.7±5 vs 2.4±5 ml/min, p> 0.05) and sodium excretion (129±200 vs 124±270 mEq/min, p>0.05) in response to AVL were similar between T+BNP and T alone. Conclusion: In PDD, the combination of PDEVI and BNP reduced LV filling pressure in response to AVL as compared to PDEVI alone. However, it did not enhance the renal response to AVL. This suggests a differential cardiac versus renal response to the maximization of cGMP system with PDEVI and BNP.
Abstract 17934: Normal Doppler Hemodynamics of Pulmonary Valve Prostheses in Adults
Hoskoppal, Arvind , Connolly, Heidi M. , Miller, Fletcher A., Blauwet, Lori A., Dearani, Joseph A. , Schaff, Hartzell V.

Mayo Clinic

Circulation | July 3, 2021 | Volume: 130 | Issue: suppl_2 | Pages: No page available

10.1161/circ.130.suppl_2.17934 Get It

Introduction: Pulmonary valve (PV) replacement is rare, so data regarding normal hemodynamics are limited. We sought to determine the normal Doppler-derived hemodynamic profiles of various PV prostheses (PVPs) in adults. Hypothesis: Doppler-derived hemodynamic profiles of normal PVPs will vary according to prosthesis type in adult patients. Methods: We performed a retrospective review of comprehensive two dimensional and Doppler echocardiographic examinations of 327 patients (median age, 35; range 18 -83 years) with normal PVPs performed early after implantation. Data were analyzed to determine mean±SD. Results: Parasternal short axis was the most commonly used window (96%) for assessment of PVPs. For the 327 PVPs, peak instantaneous gradient was 25±11 mmHg, mean systolic gradient was 13.1±6.1 mmHg, and mean right ventricular outflow tract velocity was 0.8±0.6 m/s. Results for selected variables analyzed by prosthesis type are listed in the Table. Pericardial prostheses had significantly lower peak gradient (21±10.1 mmHg; P=0.002) compared with porcine (25±9.7 mmHg), mechanical (26±16.6 mmHg), bovine venous (34±15.5 mmHg) and homograft PVPs (35±8.4 mm Hg). Conclusions: This is the largest series reporting normal Doppler-derived hemodynamic profiles of PVPs. This study establishes normative values for Doppler-derived variables for normal PVPs implanted in adults. Pericardial prostheses had the optimal hemodynamic profile in this patient population.
Abstract 17883: Racial and Insurance disparities in Paroxysmal Supraventricular Tachycardia Ablation
Patel, Nileshkumar , Patel, Achint , Patel, Neil , Deshmukh, Abhishek , Dhaduk, Grishma, Manvar, Sohilkumar, Arora, Shilpkumar , Patel, Nilay , Badheka, Apurva O., Paydak, Hakan, González, Juan Fernández , Myerburg, Robert J. , Mitrani, Raul D. , Solanki, Shantanu , Kowalski, Marcin

Mayo Clinic

Circulation | July 3, 2021 | Volume: 130 | Issue: suppl_2 | Pages: No page available

10.1161/circ.130.suppl_2.17883 Get It

Objective: To identify racial and/or health insurance disparities in the population undergoing ablation for paroxysmal supraventricular tachycardia(PSVT). Method: We identified adult patients (pts) admitted with principle diagnosis of PSVT by ICD 9 code 427.0 who had catheter ablation (ICD 9 code - 37.34), using the Nationwide Inpatient Sample (2000-2011). We stratified patients by race (White, Black, Hispanic, and other minority racial groups)and insurance status, and a hierarchical mixed effect multivariate model was created to identify independent predictors of PSVT ablation. Results: 64,564(20.2%) patients underwent ablation out of 319,579 patients admitted for PSVT during the period of 2000-2011. In absolute numbers, the majority of ablations were performed in Whites (58.7%) and patients with Medicare (56.3%) or private insurance (30.1%). After adjusting for confounding factors, the odds of having ablation were lower in Black pts (compare to White), and Medicare, Medicaid, and Uninsured pts (compare to private insurance) (see table). Other predictors of lower rate of ablations were: older age and female patients while odds of receiving ablation were higher for elective admissions and in teaching hospitals (p<0.001 for all comparisons). Conclusion: In a population of pts admitted for PSVT, those without private insurance and Black pts were less like to be treated with catheter ablation; and, this disparity persisted from 2000-2011. Since catheter ablation for PSVT is generally considered a curative procedure, future studies are needed to identify the factors that lead to these disparities of care.
Abstract 17689: Imaging Mitochondrial Function of Mesenchymal Stem Cells Transplanted to the Myocardium
Franchi, Federico , Rodriguez‐Porcel, Martin , Peterson, Karen M. , Paulmurugan, Ramasamy , Lerman, Amir

Mayo Clinic

Circulation | July 3, 2021 | Volume: 130 | Issue: suppl_2 | Pages: No page available

10.1161/circ.130.suppl_2.17689 Get It

Introduction: Stem cells have poor survival after transplantation, what can limit the use of these therapies. Mitochondrial dysfunction has been recognized as a limiting event that can lead to cell death. Here, we hypothesized that the mitochondrial function of progenitor cells can be monitored in vivo using reporter gene-based molecular imaging. A better understanding of the biology of transplanted stem cells in the ischemic myocardium can lead to optimization of cell therapies. Methods: Using RT-PCR we identified the antioxidant NAD(P)H:Quinone oxidoreductase (NQO1) enzyme as a marker of mitochondrial dysfunction in mouse Mesenchymal Stem Cells (MSCs) that were treated with a mitochondrial stressor, diethyl maleate (DEM). We then constructed a luciferase reporter gene driven by the NQO1 promoter. After in vitro validation, MSCs were transplanted into a mouse model of ischemia/reperfusion (IR, n=4) and mitochondrial function was monitored by bioluminescence imaging. Results: MSCs treated with DEM had an increase in NQO1 reporter gene signal that inversely correlated with the amount of the mitochondrial by-product adenosine tri-phosphate (ATP, r = -0.9643, p = 0.0028; Fig 1A). Mitochondrial dysfunction was preserved by the use of a mitochondria-targeted antioxidant Mito-Tempo (MT), correcting ATP and NQO1 luciferase signal. In vivo studies showed that MSCs yielded higher Firefly luciferase activity in IR mice compared to sham and this signal was normalized when cells were pre-treated with MT (Fig 1B). Data was confirmed by ex vivo measurement of Firefly luciferase activity, which was 4.9-fold higher in the IR group than in shams, after correction for cell number (Fig 1C). Conclusions: We have developed a novel imaging strategy that allows noninvasive assessment of the mitochondrial status of transplanted stem cells in the ischemic myocardium. Knowing when transplanted cells “suffer’ from mitochondrial dysfunction may allow optimization of these therapies.
Abstract 17686: Appropriate Use and Clinical Impact of Early Echocardiograms in Hospitalized Patients
Kadkhodayan, Ana, Dailey, Eric J. , Buechler, Tamara, Newman, James S. , Chiriac, Anca Eduard , Pislaru, Sorin V. , Pellikka, Patricia A.

Mayo Clinic

Circulation | July 3, 2021 | Volume: 130 | Issue: suppl_2 | Pages: No page available

10.1161/circ.130.suppl_2.17686 Get It

Introduction: Transthoracic echocardiography (TTE) is a versatile tool for investigating cardiac function in hospitalized patients, but it was recently suggested that only a fraction of the studies result in an active change in management. The importance of early inpatient TTE to guide management and rule out important alternative pathology has not been previously investigated. The opinion of the referring provider has never been systematically surveyed. Hypothesis: Appropriate use (AU) of TTE in hospitalized patients has significant implications for patient care, even without resulting in direct alterations in management. Methods: We conducted a prospective review of 546 consecutive echocardiograms performed within 72 hours of hospital admission. An electronic survey consisting of 6 questions pertinent to rationale for TTE and consequences to patient care was sent to physicians. AU was independently determined by two investigators blinded to survey results and clinical outcomes, with differences adjudicated by a third independent investigator. Results: Of 546 TTEs included in this study, 526 (96%) were appropriate, 2% inappropriate, and 2% uncertain. Although only 48% of responders actively changed management after TTE results, 97% thought the TTE answered their clinical question. At least one new medication change occurred in 190 (35%) patients. Moreover, 95% of physicians would do another TTE in a similar situation, either to guide cardiac therapy, rule out contributing cardiac pathology, or support their current therapeutic plan. Only 5% of responders would not order another TTE if given a similar presentation in the future. Furthermore, our study uncovered a high incidence of unexpected findings (33% of TTEs), ranging from new decrease in LV systolic function, new valvular dysfunction, to pericardial effusion and new aortic aneurysm. These findings have significant clinical implications for the individual patient. Conclusions: Most early inpatient TTEs at our institution were appropriate and answered a specific clinical question important for management decisions. Even those not directly altering the acute therapeutic strategy impacted clinical course. A large number of significant incidental findings were recorded.
Abstract 17665: Complementary Role of Von Willebrand Factor Indices to Brain Natriuretic Peptide in Hypertrophic Cardiomyopathy
Kusumoto, Hana , Blackshear, Joseph L.

Mayo Clinic

Circulation | July 3, 2021 | Volume: 130 | Issue: suppl_2 | Pages: No page available

10.1161/circ.130.suppl_2.17665 Get It

Introduction: In hypertrophic cardiomyopathy (HCM), brain natriuretic peptide (BNP) has been weakly associated with septal thickness, diastolic function parameters, resting left ventricular outflow tract gradient ([[Unable to Display Character: &#8710;]]P), and more strongly associated with prognosis. Von Willebrand factor activity is known to be altered in HCM, and acquired bleeding may occur in up to ¼ of patients. Hypothesis: We hypothesized that indices of von Willebrand factor (VWF) activity would be more strongly related to [[Unable to Display Character: &#8710;]]P than BNP. Methods: We compared BNP and three independent measures of VWF function to echo/Doppler parameters in 84 HCM patients. Results: In obstructive (resting [[Unable to Display Character: &#8710;]]P ≥30 mm Hg), n-58 versus labile HCM (resting [[Unable to Display Character: &#8710;]]P <30 mm Hg, Valsalva [[Unable to Display Character: &#8710;]]P ≥30 mm Hg), n=28, VWF multimers were abnormal in 90% versus 52% (p=0.0005), VWF activity to antigen ratio was markedly lower, 0.76±0.09 vs 0.89±0.16, p<0.0001, and PFA markedly prolonged, 207±75 versus 129±61 seconds (p<0.0001), while BNP was moderately higher, 331±273 versus176±163 pg/ml, p=0.007. BNP correlated (Spearman rho, ρ), most strongly with echocardiographic E/e’ (ρ=0.51, p<0.001) and left atrial volume (ρ=0.34, p=0.003) but not peak gradient, [[Unable to Display Character: &#8710;]]P, (ρ=0.13, NS), while BNP normalized for age and gender was weakly associated with [[Unable to Display Character: &#8710;]]P, ρ=0.26,p=0.02 and powerfully associated with septal thickness (ρ=0.50, p<0.001), and left ventricular mass index (ρ=0.43, p<0.001). In contrast, quantitative VWF activity measures correlated strongly with [[Unable to Display Character: &#8710;]]P, VWF activity/antigen (ρ=-0.59, p<0.0001), and PFA (ρ=0.51, p<0.0001). In HCM patients with bleeding (n=31), VWF antigen level was higher than in those without bleeding suggesting that the combination of elevated total VWF antigen and absent high molecular weight multimers may be involved in the causation of bleeding. Conclusion: Our data suggest that BNP elevations are associated most strongly with E/e’, left atrial volume, septal thickness, and left ventricular mass, while VWF activity indices more strongly reflect [[Unable to Display Character: &#8710;]]P, and may thus have a complementary role in assessing therapeutic responses and prognosis. Loss of high molecular weight VWF multimers and elevated total VWF antigen concentration may be a novel marker of bleeding risk from acquired von Willebrand syndrome in HCM.
Abstract 17636: Health Status Outcomes in Patients With Radial Access for PCI
Baklanov, Dmitri , Tang, Fengming, Jones, Philip G. , Ting, Henry H. , Curtis, Jeptha P. , Spertus, John A.

Mayo Clinic

Circulation | July 3, 2021 | Volume: 130 | Issue: suppl_2 | Pages: No page available

10.1161/circ.130.suppl_2.17636 Get It

Background: While concerns about the safety and procedural success of radial, as opposed to femoral, access for PCI have largely been abated, the association of radial access with patients’ health status recovery has not been explored. To address this gap in knowledge, we compared the symptoms, physical function and quality of life 1 year after PCI in patients treated with radial, as compared with femoral, access. Methods: This is a 10-center study of PCI, in whom 48 of 139 (35%) interventionalists used both radial and femoral approaches between 2009-2010. A total 2628 patients without prior CABG were interviewed and followed for one year. The previously validated Seattle Angina Questionnaire (SAQ) was used to assess disease-specific health status and the EQ-5D was used to quantify generic quality of life. Clinical characteristics and health status outcomes were compared between 296 radial and 2332 femoral PCI procedures. Results: Radial access was used in 11.2% of patients. No demographic (age, gender, race) or clinical factors (e.g. BMI, smoking, diabetes, hypertension, renal disease or prior cardiac history) were associated with radial use, except for an increased use among those with PAD (10.5% radial vs. 6.8% femoral, p=0.022) but reduced use among those with prior PCI (38.3% vs. 32.1%, p=0.037). There was no difference in health status outcomes based on SAQ angina frequency and quality of life, or the EQ-5D at baseline, 6 months or one year (table). Conclusion: In this multi-center observational registry, there was no association of radial access with long-term health status outcomes. These data suggest that there are no offsetting concerns about patients’ long-term health status benefits to counterbalance the peri-procedural safety benefits of a radial approach.
Abstract 17453: Clinical Features of Peripartum Spontaneous Coronary Artery Dissection
Gulati, Rajiv , Rose, Carl H., Best, Patricia J.M. , Tweet, Marysia S. , Hayes, Sharonne N.

Mayo Clinic

Circulation | July 3, 2021 | Volume: 130 | Issue: suppl_2 | Pages: No page available

10.1161/circ.130.suppl_2.17453 Get It

Background: Spontaneous coronary artery dissection (SCAD) is the principal cause of peripartum myocardial infarction (MI). Clinical features remain incompletely understood. Methods: Medical records of all women enrolled in a SCAD registry at the Mayo Clinic were reviewed to identify those who were either pregnant or ≤12 weeks postpartum at time of initial event. Diagnosis of SCAD was confirmed with coronary angiography in all cases. Obstetrical outcomes and incidence of recurrent SCAD events were assessed. Results: In total, 38 of 363 women enrolled in the registry met criteria for peripartum MI due to SCAD. Mean age at time of SCAD was 36±3 (range 27-42) years; 3 patients were pregnant at the time of initial event, and all pregnancies except 2 resulted in a live birth. Ten (26%) were diagnosed with multivessel SCAD (MV-SCAD). Most (60%) postpartum events occurred within 30 days of delivery. Antecedent co-morbidities included gestational hypertension/preeclampsia (9), fibromuscular dysplasia (7), gestational diabetes (4), and mixed connective tissue disease (1). Compared to US population birth data, women with peripartum SCAD were more likely to be ≤ 30 years at the time of first delivery (60% vs 42%) and more often multiparous (80% vs 59%). On long-term follow-up (median 3.7 years, IQR 1.1-7.1), 5 (13%) women experienced recurrent SCAD, with one episode occurring following a subsequent pregnancy. MV-SCAD was not associated with increased risk of recurrence (p=0.44). Conclusion: Women with peripartum SCAD are both older than the general obstetrical population at the time of first pregnancy and frequently multiparous at time of initial SCAD event. The highest frequency of SCAD was encountered during the first postpartum month, suggesting variations in hormonal and hemodynamic factors may contribute to SCAD events in susceptible women.